U.S. markets closed

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
5.250.00 (0.00%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CAD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/20/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
661.55M686.92M695.71M756.00M919.19M827.58M
Enterprise Value 3
281.00M331.77M340.27M260.68M452.19M459.14M
Trailing P/E
14.5816.9726.10118.37140.4062.00
Forward P/E 1
N/A555.56119.0597.09N/A32.68
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
3.433.593.935.5910.7418.31
Price/Book (mrq)
0.800.780.790.951.171.02
Enterprise Value/Revenue 3
1.417.206.175.768.4910.02
Enterprise Value/EBITDA 7
3.4728.1316.3710.4118.471.14k

Trading Information

Stock Price History

Beta (5Y Monthly) 0.67
52-Week Change 3-29.15%
S&P500 52-Week Change 333.06%
52 Week High 37.45
52 Week Low 34.88
50-Day Moving Average 35.32
200-Day Moving Average 35.34

Share Statistics

Avg Vol (3 month) 3331.89k
Avg Vol (10 day) 3172.7k
Shares Outstanding 5126.01M
Implied Shares Outstanding 6N/A
Float 103.65M
% Held by Insiders 118.55%
% Held by Institutions 131.23%
Shares Short (May 30, 2021) 42.83M
Short Ratio (May 30, 2021) 49.13
Short % of Float (May 30, 2021) 4N/A
Short % of Shares Outstanding (May 30, 2021) 42.25%
Shares Short (prior month Apr 29, 2021) 42.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 23.70%
Operating Margin (ttm)-10.55%

Management Effectiveness

Return on Assets (ttm)-1.16%
Return on Equity (ttm)5.25%

Income Statement

Revenue (ttm)199.75M
Revenue Per Share (ttm)1.53
Quarterly Revenue Growth (yoy)0.50%
Gross Profit (ttm)81.69M
EBITDA 7.14M
Net Income Avi to Common (ttm)47.33M
Diluted EPS (ttm)0.36
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)411.11M
Total Cash Per Share (mrq)3.26
Total Debt (mrq)41.9M
Total Debt/Equity (mrq)5.05
Current Ratio (mrq)4.06
Book Value Per Share (mrq)6.56

Cash Flow Statement

Operating Cash Flow (ttm)26.17M
Levered Free Cash Flow (ttm)-124.27M